Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends

P Montuschi, G Ciabattoni - Journal of medicinal chemistry, 2015 - ACS Publications
Inhaled bronchodilators, including long-acting muscarinic receptor antagonists (LAMA) and
long-acting β2-adrenoreceptor agonists (LABA), are the mainstay of pharmacological …
被引用次数：87 相关文章

Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends

P Montuschi, C Giovanni - JOURNAL OF MEDICINAL …, 2015 - publicatt.unicatt.it
Inhaled bronchodilators, including long-acting muscarinic receptor antagonists (LAMA) and
long-acting β2-adrenoreceptor agonists (LABA), are the mainstay of pharmacological …

Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends

P Montuschi, G Ciabattoni - Journal of medicinal chemistry, 2015 - pubmed.ncbi.nlm.nih.gov
Inhaled bronchodilators, including long-acting muscarinic receptor antagonists (LAMA) and
long-acting β2-adrenoreceptor agonists (LABA), are the mainstay of pharmacological …

Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends.

P Montuschi, G Ciabattoni - Journal of Medicinal Chemistry, 2015 - europepmc.org
Inhaled bronchodilators, including long-acting muscarinic receptor antagonists (LAMA) and
long-acting β2-adrenoreceptor agonists (LABA), are the mainstay of pharmacological …

Bronchodilating drugs for chronic obstructive pulmonary disease: Current status and future trends

P Montuschi, G Ciabattoni - Journal of Medicinal Chemistry, 2015 - hero.epa.gov
Inhaled bronchodilators, including long-acting muscarinic receptor antagonists (LAMA) and
long-acting β2-adrenoreceptor agonists (LABA), are the mainstay of pharmacological …